Home >> Signaling Pathways >> TGF-β / Smad Signaling >> Bcr-Abl

Bcr-Abl(Bcr-Abl酪氨酸激酶)

Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).

Products for  Bcr-Abl

  1. Cat.No. 产品名称 Information
  2. GC14396 Ponatinib (AP24534)

    普纳替尼; AP24534

    An inhibitor of native and mutant Bcr-Abl
  3. GC15197 Saracatinib (AZD0530)

    塞卡替尼; AZD0530

    A dual inhibitor of c-Src and Abl
  4. GC11759 Imatinib Mesylate (STI571)

    甲磺酸伊马替尼; STI571 Mesylate; CGP-57148B Mesylate

    An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit
  5. GC13343 Bosutinib (SKI-606)

    伯舒替尼,SKI-606

    An inhibitor of Src and Abl kinases
  6. GC14129 Nilotinib(AMN-107)

    尼洛替尼; AMN107

    Nilotinib(AMN-107)(尼洛替尼)是一种选择性口服酪氨酸激酶抑制剂,可抑制天然Bcr-Abl(WT p210)和突变型Bcr-Abl(E281K、E292K、F317L、M351T和F486S)的自磷酸化,IC50值分别为20、42、31、38、29和41nM。
  7. GC13102 XL228

    N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺,XL-228;XL 228

    A tyrosine kinase inhibitor
  8. GC14237 Nilotinib monohydrochloride monohydrate

    尼洛替尼盐酸盐一水合物; AMN107 monohydrochloride monohydrate

    A Bcr-Abl inhibitor
  9. GC10914 AST 487

    NVP-AST 487

    A multi-kinase inhibitor
  10. GC14592 KW 2449

    [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮

    A multi-kinase inhibitor
  11. GC10638 AT9283 A broad spectrum kinase inhibitor
  12. GC15568 Dasatinib (BMS-354825)

    达沙替尼; BMS-354825

    An inhibitor of Abl and Src

Items 51 to 61 of 61 total

per page
  1. 1
  2. 2

Set Descending Direction